During the COVID-19 pandemic, mRNA vaccines came to the rescue, developed in record time and saving lives worldwide. Researchers in the Precision Vaccines Program at Boston Children’s Hospital have developed two novel technologies that could make these and future mRNA vaccines more potent and longer-lasting—at smaller doses and with fewer side effects.
Creating the next generation of mRNA vaccines: Study shows potential for lower-doses, longer-lasting protection
